Webinar on the use of platform technologies in the non-clinical and clinical domains

Date

, -

Location

Online
European Medicines Agency, Amsterdam, the Netherlands
Live broadcast

Event summary

The proposal for the EU pharmaceutical legislation introduces the concepts of platform technologies and platform marketing authorisation. 
The European Medicines Agency organises a webinar bringing together regulators and medicine developers to discuss the use of platform technologies beyond the quality and manufacturing domains.

We invite interested parties to share insights and case studies on the use of non-clinical and clinical platform technologies and platform marketing authorisation (ITFsecretariat@ema.europa.eu).

The main objectives of the webinar are:

•    Clarifying how the current EU legal framework allows for the development and marketing of individualised therapies (n=1) and for the use of prior knowledge in Marketing Authorisation dossiers.
•    Presenting case studies on the use of platform technologies in the non-clinical and clinical domains and exploring their possible applications and values.
•    Discussing the challenges and identify opportunities related to the use of platform approaches.
•    Facilitating the implementation of the NPL provisions on platform technologies and platform marketing authorisation.

Documents

Live broadcast

You should see the live broadcast on pressing the 'play' icon in the video window, or a message stating that the event has not started yet.

To optimise video quality, once the video is playing we recommend clicking on the ‘Wheel’ symbol in the video window then selecting the Quality Option up to 1080p.

If the video window is blank, or if you experience other difficulties viewing the broadcast, please try connecting directly to the EMA's Vimeo Channel 1.

For technical information about the required network security settings, please see this Vimeo help page.

For further assistance, please consult the EMA Service desk.

Share this page